Ischemia modified albumin (IMA), as measured using the albumin cobalt binding test, is currently the most promising biomarker for early detection of ischemia before the onset of irreversible cardiac injury. For its association with ischemia and low levels of oxygen, we suggested it as a marker of physiological hypoxia during placentation.

Ischemia modified albumin as a marker of physiological hypoxia during placentation

LIPPI, Giuseppe;SALVAGNO, GIAN LUCA;FRANCHI, Massimo Piergiuseppe;
2006

Abstract

Ischemia modified albumin (IMA), as measured using the albumin cobalt binding test, is currently the most promising biomarker for early detection of ischemia before the onset of irreversible cardiac injury. For its association with ischemia and low levels of oxygen, we suggested it as a marker of physiological hypoxia during placentation.
IMA; ischemia; fetal hypoxia
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11562/430375
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact